Medvic Formulations Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-06-2024
- Paid Up Capital ₹ 0.10 M
as on 22-06-2024
- Company Age 6 years 5 months
- Last Filing with ROC 31 Mar 2023
- Revenue 107.25%
FY 2022
- Profit 120.91%
FY 2022
- Ebitda 129.85%
FY 2022
- Net Worth 362.00%
FY 2022
- Total Assets 85.92%
FY 2022
About Medvic Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per the Ministry of Corporate Affairs (MCA) records.
Sulabh Saxena, Ashok Singh, Aradhana Srivastava, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300UP2018PTC103038
- Company No.
103038
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Greater Noida, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medvic Formulations Private Limited offer?
Medvic Formulations Private Limited offers a wide range of products and services, including Healthcare Products & Aids, Adult Diapers, Hand Sanitizers & Personal Hygiene, Sanitary Pad.
Who are the key members and board of directors at Medvic Formulations?
Board Members(4)
Financial Performance and Corporate Structure Insights of Medvic Formulations.
Medvic Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 107.25% increase. The company also saw a substantial improvement in profitability, with a 120.91% increase in profit. The company's net worth Soared by an impressive increase of 362%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medvic Formulations?
In 2022, Medvic Formulations had a promoter holding of 90.10% and a public holding of 9.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
20 years 8 months Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medvic Formulations?
Unlock and access historical data on people associated with Medvic Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medvic Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medvic Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
